Evidence map›Paper›PMID 42515632›Full record

ReviewViruses2026

Age-Dependent Differences in the Antiviral Response of the Respiratory Epithelium.

Leah Setar, Bria Coates

Abstract readReview
In one paragraph

Review in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leah SetarAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.ORCID 0009-0003-0822-667X
Bria CoatesAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.ORCID 0000-0003-4264-5440

Funding

The Cell Phenotyping and Mouse CoreP01HL154998 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KAREN M RIDGE · 2021 to 2026
$18.9M
Training Program In Lung SciencesT32HL076139 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KAREN M RIDGE, Jacob I Sznajder · 2004 to 2026
$9.6M
Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumoniaR01HL168672 · NHLBI · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI Bria M Coates · 2023 to 2026
$2.5M
Viral and Host Dynamics during Pediatric COVID-19 and Respiratory Virus Co-InfectionR01AI177498 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Bria M Coates, Judd F Hultquist · 2024 to 2026
$2.4M
National Heart Lung and Blood Institute P01HL154998National Heart Lung and Blood Institute R01HL168672National Institute of Allergy and Infectious Diseases R01AI177498NHLBI NIH HHS P01 HL154998NHLBI NIH HHS R01 HL168672NHLBI NIH HHS T32 HL076139NIAID NIH HHS R01 AI177498NIH HHS 1T32HL076139
6 · The paper itself

Abstract

Age is an established risk factor for severe viral respiratory infections, yet the mechanisms driving increased severity of illness in infants and older adults remain incompletely understood. The respiratory epithelium is the primary target of viral infection and how it orchestrates the immune response may be a key determinant of clinical outcomes. The profound age-related difference in susceptibility to severe Coronavirus disease 2019 (COVID-19) brought increased attention to the epithelial response to viral infection in children and adults, adding significant data to the preexisting body of work largely focused on influenza and respiratory syncytial virus (RSV). This review synthesizes current knowledge on the structural and functional differences in the respiratory epithelium between children and adults at baseline and during viral infection. We review the variable and heterogenous human studies in addition to in vitro and animal model data to identify key gaps in current knowledge. Here, we advocate for a more complete understanding of age-dependent differences in the respiratory epithelial response to viral infection to uncover therapeutic targets for prevention and treatment of viral-associated respiratory failure.

Indexed as

Respiratory MucosaRespiratory Tract InfectionsVirus DiseasesAdultAge FactorsAnimalsChildCOVID-19HumansImmunity, InnateInfantRespiratory Syncytial Virus InfectionsSARS-CoV-2innate immune responseinterferon signalingpediatric immunityrespiratory epitheliumrespiratory viral infections

Identifiers

PMID42515632
PMCPMC13431498

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.